You are here » Home » Companies » Company Overview » Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd.

BSE: 524470 Sector: Health care
NSE: N.A. ISIN Code: INE312C01025
BSE 00:00 | 24 Apr 2020 Syncom Formulations (India) Ltd is not traded on BSE in the last 30 days
NSE 05:30 | 01 Jan 1970 Syncom Formulations (India) Ltd Not listed in NSE

Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
OPEN 1.10
PREVIOUS CLOSE 1.00
VOLUME 2587979
52-Week high 1.36
52-Week low 0.39
P/E 6.47
Mkt Cap.(Rs cr) 86
Buy Price 1.10
Buy Qty 3.00
Sell Price 1.10
Sell Qty 25370.00
OPEN 1.10
CLOSE 1.00
VOLUME 2587979
52-Week high 1.36
52-Week low 0.39
P/E 6.47
Mkt Cap.(Rs cr) 86
Buy Price 1.10
Buy Qty 3.00
Sell Price 1.10
Sell Qty 25370.00

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988, Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda. In addition to pharmaceutical formulations ...> More

Syncom Formulations (India) Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   86
EPS - TTM () [*S] 0.17
P/E Ratio (X) [*S] 6.47
Face Value ()   1
Latest Dividend (%)   2.00
Latest Dividend Date 21 Sep 2017
Dividend Yield (%) 0.00
Book Value / Share () [*S] 1.78
P/B Ratio () [*S] 0.62
[*C] Consolidated     [*S] Standalone    

Syncom Formulations (India) Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 52.32 47.66 9.78
Other Income 1.26 1.25 0.8
Total Income 53.59 48.91 9.57
Total Expenses 48 44.04 8.99
Operating Profit 5.58 4.87 14.58
Net Profit 3.5 3.82 -8.38
Equity Capital 78.07 78.07 -
> More on Syncom Formulations (India) Ltd Financials Results

Syncom Formulations (India) Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Vivimed Labs. 13.80 3.68 114.40
Zim Labs. 69.05 -0.93 111.72
Mangalam Drugs 59.60 4.93 94.35
Syncom Formul. 1.10 10.00 85.88
SMS Lifesciences 282.85 2.04 85.42
Everest Organics 92.35 -3.04 73.88
Jagsonpal Pharma 28.05 1.45 73.49
> More on Syncom Formulations (India) Ltd Peer Group

Syncom Formulations (India) Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 40.14
Banks/FIs 0.01
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 54.15
Custodians 0.00
Other 5.70
> More on Syncom Formulations (India) Ltd Share Holding Pattern

Syncom Formulations (India) Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.79% NA -0.83% -1.21%
1 Month 86.44% NA 17.44% 17.35%
3 Month 50.68% NA -24.72% -25.26%
6 Month 77.42% NA -19.72% -20.96%
1 Year 3.77% NA -19.79% -21.93%
3 Year -41.80% NA 5.64% -0.69%

Syncom Formulations (India) Ltd - STOCK STRENGTH

Today's Low/High 1.05
1.10
Week Low/High 0.86
1.00
Month Low/High 0.58
1.00
YEAR Low/High 0.39
1.00
All TIME Low/High 0.14
15.00